The ESCC MiRNAs have been found to repress the expression of methyl CpG binding protein MBD2; and knocking down MBD2 can increase the efficiency of reprogramming (Subramanyam et al., 2011; Lee et al., 2013). The gene discussed is MBD2; the disease is esophageal squamous cell carcinoma.